Mexico updates its legislation with key reforms and amendments in connection with health regulated products and services

As had been anticipated months earlier, on January 15, 2026, the decree amending, adding to, and repealing various provisions of the General Health Law was published in the Federal Official Gazette.

As mentioned in previous articles, these reforms focus on various issues on which both the current and prior administrations have placed particular emphasis. Many of the changes seek to tighten restrictions on the importation, marketing, and use of various products, as well as the provision of health-related services.

Likewise, the decree also establishes in its diverse amendments to the GHL the purpose to expand the powers of health authorities and the implementation of public health services.

Relevant topics include digital health, blood derivatives, domestic investment in the pharmaceutical production chain, health supplies and medical devices, as well as the development of scientific research and innovative health products.

These amendments mainly refer to vaping devices, precursors and toxic products, consolidated procurements and administrative facilitations, verification and surveillance powers, blood derivatives and blood products, digital health, and medical liability.

If you want to consult the details of the approved modifications, you can consult this previous publication.